In line with this hypothesis, we have observed a marked decrease in the expression levels of anti-inflammatory Cav-1 and BMPR2 within the lung vascular endothelium, which appear to be instrumental for the expansion of an abnormal EC phenotype evident in PAH. This evidence concerns the gene CAV1 and pulmonary arterial hypertension.